试验雷达 AI | ||
|---|---|---|
临床试验 NCT07367555 针对糖尿病目前已完成。请查看临床试验雷达卡片视图和 AI 发现工具了解所有详情，或在此提出任何问题。 | ||
一个试验符合筛选条件
卡片视图
Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients I期 360
临床试验详情主要以英语提供。然而，试验雷达 AI可以提供帮助！只需点击“试验详解”即可查看和讨论您选择的语言的试验信息。
临床试验NCT07367555旨在研究治疗，主要针对糖尿病。这是一项I期 干预性研究试验，试验状态为已完成。试验开始于2024年10月1日，共计划招募360名患者。该研究由Ariba Shafiq主导，已于2025年3月31日完成。试验数据来源于ClinicalTrials.gov，最后更新时间为2026年1月26日。
简要概括
Total of 360 participants were enrolled and prescribed oral 200 mg SGLT-2 tablet. All participants were followed-up for about three months. Body mass index was measured before and after three months and mean change in BMI was assessed.
官方标题
Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients"
疾病
糖尿病其他研究标识符
- 14
NCT编号
实际开始日期
2024-10-01
最近更新发布
2026-01-26
预计完成日期
2025-03-31
计划入组人数
360
研究类型
干预性研究
试验分期 (阶段)
I期
试验状态
已完成
关键词
Body Mass Index
Glycemic Index
Sodium Glucose Co-transporter-2 Inhibitors
Glycemic Index
Sodium Glucose Co-transporter-2 Inhibitors
主要目的
治疗方法
分配方式
随机
干预模型
平行
盲法
单盲
试验组/干预措施
| 参与者组/试验组 | 干预措施/治疗方法 |
|---|---|
实验性Group A participants with Type II Diabetes Mellitus Randomly 180 Individuals with diagnosed type 2 Diabetes Mellitus were allocated group A. These individuals were prescribed oral 100 gram Empagliflozin tablet along with diet plan and exercise. All individuals were followed-up in OPD for 3 months. After 3 months, individuals were assessed again for height, weight, and BMI. Changes in weight and BMI were calculated. | Oral 100 gram Empagliflozin tablet along with diet plan and exercise oral 100 gram Empagliflozin tablet along with diet plan and exercise |
阳性对照Group B participants with Type II Diabetes Mellitus Randomly 180 Individuals with diagnosed type 2 Diabetes Mellitus were allocated group A. These individuals were prescribed oral 100 gram Empagliflozin tablet along with diet plan and exercise. All individuals were followed-up in OPD for 3 months. After 3 months, individuals were assessed again for height, weight, and BMI. Changes in weight and BMI were calculated. | Diet plan and exercise Only Life style modification was advised. Changes in BMI were assessed. |
主要终点
次要终点
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Weight | Weight is measured in Kilograms | 03 Months |
| 结果指标 | 度量标准描述 | 时间框架 |
|---|---|---|
Height | Height is measured in meters | 03 months |
资格标准
适龄参与研究
成人, 老年人
最低年龄要求
30 Years
适龄性别
全部
- Individuals diagnosed with type II diabetes mellitus ( blood sugar level (random) at presentation was above 186 mg/dl and HbA1c was more than 6.5% on laboratory investigations)
- Individuals already taking trail drug or any other anti-glycemic drug or insulin for >6 months
Ariba Shafiq研究责任方
Ariba Shafiq, 申办者-研究者, Principal Investigator, Combined Military Hospital Multan
没有联系数据。
1 位于 1 个国家/地区的研究中心
Punjab Province
CMH Multan, Multan, Punjab Province, 60010, Pakistan